5.20
0.19%
0.010
Handel nachbörslich:
5.15
-0.05
-0.96%
Candel Therapeutics Inc Aktie (CADL) Neueste Nachrichten
Candel Therapeutics eyes new indication for CAN-3110 in melanoma following positive preclinical results - Proactive Investors USA
Candel Therapeutics to Present Preclinical Data at SITC - GlobeNewswire
Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma - StockTitan
Candel Therapeutics: A Low-Price Oncolytic Virus Plays Further Along Than You Think - Seeking Alpha
Candel Therapeutics Advances in Cancer Treatment Trials - Yahoo Finance
Candel Therapeutics Showcases Innovative Cancer Therapy - GlobeNewswire
Candel Therapeutics Showcases Innovative Cancer Therapy Candidates at 16th Annual International Oncolytic Virotherapy Conference (IOVC) - StockTitan
Candel Therapeutics Prices IPO At $8/Share - RTTNews
Where are the Opportunities in (CADL) - Stock Traders Daily
Candel Therapeutics Share PriceCADL, RNS News, Articles, Quotes, & Charts (NASDAQ:CADL) - Proactive Investors USA
Candel Therapeutics Poised for Breakthrough in Cancer Therapies, Key Trials to Read Out by Year-End - Proactive Investors UK
Candel Therapeutics, Inc. (NASDAQ:CADL) Short Interest Update - MarketBeat
(CADL) Trading Advice - Stock Traders Daily
Candel Therapeutics, Inc. (NASDAQ:CADL) Major Shareholder Estuardo Aguilar-Cordova Sells 15,000 Shares - MarketBeat
Candel therapeutics investor sells $243,834 in stock By Investing.com - Investing.com South Africa
How To Trade (CADL) - Stock Traders Daily
Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting - The Manila Times
Candel Therapeutics to Present Preclinical Data on - GlobeNewswire
Candel therapeutics insider sells shares worth over $240k By Investing.com - Investing.com South Africa
Candel therapeutics insider sells shares worth over $240k - Investing.com India
Candel Therapeutics, Inc. (NASDAQ:CADL) Major Shareholder Estuardo Aguilar-Cordova Sells 1,800 Shares - MarketBeat
Citigroup Raises Cogent Biosciences (NASDAQ:COGT) Price Target to $15.00 - Defense World
Citi raises Cogent price target on bezuclastinib potential - Investing.com India
Deeper Dive: Understanding Cg Oncology Inc. (CGON) Through its Various Ratios - The Dwinnex
(CADL) Proactive Strategies - Stock Traders Daily
Gaining Ground: Cogent Biosciences Inc (COGT) Closes Lower at 10.65, Down -3.01 - The Dwinnex
Cg Oncology Inc. [CGON] Stock sold by Insider Song Hong Fang for $23.0 million - Knox Daily
Capricor Therapeutics Shares Rise in Premarket on Plans to File Application for Deramiocel - MarketWatch
Cintas Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga
Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Kayne Anderson Rudnick Investment Management LLC Trims Holdings in Copart, Inc. (NASDAQ:CPRT) - Defense World
Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks
Cadence Design Systems Inc. stock rises Monday, still underperforms market - MarketWatch
Xponance Inc. Has $24.15 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World
Hood River Capital Management LLC Has $13.71 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World
Mizuho recommends buying Corbus following its drop post-Novo's obesity data (NASDAQ:CRBP) - Seeking Alpha
Is it possible to buy Candel Therapeutics Inc(CADL) shares at a good price now? - US Post News
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World
Mount Yale Investment Advisors LLC Sells 2,003 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Kayne Anderson Rudnick Investment Management LLC Trims Stake in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World
Revenues Working Against Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Following 27% Dive - Simply Wall St
Pacer Advisors Inc. Boosts Holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN) - MarketBeat
Sands Capital Ventures LLC Cuts Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - Defense World
Sands Capital Ventures LLC Trims Stock Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - MarketBeat
Davidson Capital Management Inc. Buys 11,978 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Did Candel Therapeutics Inc (CADL) perform well in the last session? - US Post News
Corbus drops after rival Novo Nordisk reports obesity drug data - XM
Choreo LLC Purchases Shares of 23,033 Coty Inc. (NYSE:COTY) - Defense World
Cadence design systems director sells $414k in company stock - Investing.com
Sienna Gestion Trims Stake in Copart, Inc. (NASDAQ:CPRT) - Defense World
Catalyst Pharmaceuticals stock hits 52-week high at $20.88 - Investing.com
Cibus price target lowered to $20 from $21 at Canaccord - TipRanks
Why Casella Waste Systems (CWST) Stock Is Falling - Benzinga
Why Cibus (CBUS) Stock Is Down 21% Wednesday - Benzinga
Cibus Shares Fall on Plan to Raise $12 Million in Offering - MarketWatch
Cadence Stock Down 16% in 3 Months: Should You Buy, Sell or Hold? - Nasdaq
Cibus sets price for 3 million share public offering - Investing.com
Glioma Clinical Trials, Treatment Drugs, Pipeline Insights, and Companies 2024 - openPR
Retail investors who hold 48% of Candel Therapeutics, Inc. (NASDAQ:CADL) gained 14%, insiders profited as well - Simply Wall St
Learn to Evaluate (CADL) using the Charts - Stock Traders Daily
Candel Therapeutics, Inc. (NASDAQ:CADL) most popular amongst individual investors who own 48%, insiders hold 30% - Yahoo Finance
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors - GlobeNewswire Inc.
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Candel Therapeutics Inc (CADL) Stock: A Year of Decreases and Increases - The InvestChronicle
Candel Therapeutics, Inc. (NASDAQ:CADL) Sees Significant Increase in Short Interest - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):